Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-Y Robert

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal Francais D'Ophtalmologie|July 30, 2013
[Corneal neovascularization: epidemiological, physiopathological, and clinical features]Y Benayoun, G Casse, R Forte, et al.
Journal Francais D'Ophtalmologie|June 9, 2001
[Cyclosporin A eyedrops: manufacturing, toxicity, pharmacokinetics and indications in 2000]P Y Robert, V Leconte, C Olivé, et al.
Journal Francais D'Ophtalmologie|May 25, 2010
[A chart for low visual acuities: experience in a center for low vision and rehabilitation]P Bonavolonta, I Travade, R Forte, et al.
Journal Francais D'Ophtalmologie|October 27, 2009
[Evaluation of NAAGA efficacy in dry eye syndrome]F Brignole-Baudouin, P-Y Robert, C Creuzot-Garcher, et al.
The American Journal of Medicine|September 1, 2001
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patientsE Liozon, F Herrmann, K Ly, et al.
Journal Francais D'Ophtalmologie|November 26, 2015
[Rationale for a diagnostic approach in non-Graves' orbital inflammation--Report of 61 patients]A Gavard-Perret, J Lagier, J Delmas, et al.
Journal Francais D'Ophtalmologie|November 1, 2006
[Ophthalmic arteries originating from external carotid arteries]A Sabatier, P Y Robert, J-P Sauvage, et al.
Journal Francais D'Ophtalmologie|July 5, 2003
[Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor]P-Y Robert, A Liekfeld, S Ranger-Rogez, et al.
Revue D'Epidemiologie Et De Sante Publique|December 10, 2002
[Dependence for daily life activities in the prison population in Western France]L Laplace, J Daniel, M Belloncle, et al.
Journal Francais D'Ophtalmologie|January 1, 1997
[Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases]P Y Robert, B Delbosc, P M Preux, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal Francais D'Ophtalmologie|July 30, 2013
[Corneal neovascularization: epidemiological, physiopathological, and clinical features]Y Benayoun, G Casse, R Forte, et al.
Journal Francais D'Ophtalmologie|June 9, 2001
[Cyclosporin A eyedrops: manufacturing, toxicity, pharmacokinetics and indications in 2000]P Y Robert, V Leconte, C Olivé, et al.
Journal Francais D'Ophtalmologie|May 25, 2010
[A chart for low visual acuities: experience in a center for low vision and rehabilitation]P Bonavolonta, I Travade, R Forte, et al.
Journal Francais D'Ophtalmologie|October 27, 2009
[Evaluation of NAAGA efficacy in dry eye syndrome]F Brignole-Baudouin, P-Y Robert, C Creuzot-Garcher, et al.
The American Journal of Medicine|September 1, 2001
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patientsE Liozon, F Herrmann, K Ly, et al.
Journal Francais D'Ophtalmologie|November 26, 2015
[Rationale for a diagnostic approach in non-Graves' orbital inflammation--Report of 61 patients]A Gavard-Perret, J Lagier, J Delmas, et al.
Journal Francais D'Ophtalmologie|November 1, 2006
[Ophthalmic arteries originating from external carotid arteries]A Sabatier, P Y Robert, J-P Sauvage, et al.
Journal Francais D'Ophtalmologie|July 5, 2003
[Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor]P-Y Robert, A Liekfeld, S Ranger-Rogez, et al.
Revue D'Epidemiologie Et De Sante Publique|December 10, 2002
[Dependence for daily life activities in the prison population in Western France]L Laplace, J Daniel, M Belloncle, et al.
Journal Francais D'Ophtalmologie|January 1, 1997
[Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases]P Y Robert, B Delbosc, P M Preux, et al.
Pageof 9